ARTICLE | Clinical News
Cyclacel preclinical data
May 3, 2010 7:00 AM UTC
CYC065 induced apoptosis in CLL cell lines with about 30-fold greater potency than selicicib in vitro. CYC065 is a second-generation inhibitor of cyclin dependent kinases 2E, 2A, 7 and 9. Data were pr...